Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153,324 | 208,650 | 236,536 | 128,369 | 165,455 |
| Marketable Securities | 27,847 | 12,873 | 12,129 | 14,322 | 14,364 |
| Receivables | 15,405 | 7,373 | 12,183 | 6,963 | 13,453 |
| TOTAL | $200,564 | $232,573 | $263,579 | $155,400 | $198,238 |
| Non-Current Assets | |||||
| PPE Net | 129,020 | 129,607 | 130,451 | 131,660 | 132,171 |
| Investments And Advances | 131,720 | 127,974 | 138,310 | 139,518 | 144,269 |
| Other Non-Current Assets | 9,270 | 9,093 | 9,055 | 8,962 | 8,850 |
| TOTAL | $270,010 | $266,674 | $277,816 | $280,140 | $285,290 |
| Total Assets | $470,574 | $499,247 | $541,395 | $435,540 | $483,528 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,521 | 4,234 | 3,915 | 2,433 | 4,551 |
| Accrued Expenses | 47,932 | 41,774 | 46,240 | 42,466 | 48,985 |
| TOTAL | $67,181 | $58,988 | $63,502 | $53,957 | $62,754 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,728 | 12,980 | 13,347 | 9,058 | 9,218 |
| Other Non-Current Liabilities | 19,692 | 16,180 | 15,888 | 15,473 | 17,161 |
| TOTAL | $206,568 | $203,704 | $205,007 | $177,696 | $180,098 |
| Total Liabilities | $273,749 | $262,692 | $268,509 | $231,653 | $242,852 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,483 | 2,453 | 2,423 | 2,371 | N/A |
| Common Shares | 620 | 612 | 604 | 593 | 590 |
| Retained earnings | -408,062 | -356,693 | -311,595 | -368,650 | -322,283 |
| Other shareholders' equity | 17,620 | 17,657 | 18,648 | 18,533 | 16,122 |
| TOTAL | $196,825 | $236,555 | $272,886 | $203,887 | $240,676 |
| Total Liabilities And Equity | $470,574 | $499,247 | $541,395 | $435,540 | $483,528 |